Sniper Medical Technology
Suzhou
About Sniper Medical Technology
Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generation technology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $18.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Oct 2024)
- Website: sniper-tech.com
- Phone: +86 0512-62809514
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/sniper-medical-technology-20495 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.